NCMP-10. SURVIVAL BENEFIT OF ANTIEPILEPTIC DRUGS IN PATIENTS WITH GLIOBLASTOMA

BACKGROUND: Symptomatic epilepsy is a common disorder in patients with brain tumor, often adversely affects the patients’ quality of life. The incidence of seizures in glioblastoma (GBM) patients has been reported to be between 40% and 60%, and most patients with GBM receive some antiepileptic drugs...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Tanaka, Hirotomo, Sasayama, Takashi, Nishihara, Masamitsu, Morikawa, Masashi, Ikeda, Mitsuru, Tanaka, Kazuhiro, Kohmura, Eiji
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692972/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.560
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak